Abstract: In order to investigate the mechanisms underlying the neuroprotective effect of ginsenoside Rb 3 , rat hippocampal neurons were primarily cultured, and exposed to 1 mM N-methyl-D-aspartate (NMDA), cell viability and lactate dehydrogenase leakage were measured. Ca 2+ influx was determined by calcium imaging with a laser confocal microscopy. The influences of ginsenoside Rb 3 on these variables were examined. Patch-clamp technique was used to observe the effects of ginsenoside Rb 3 on NMDA-evoked current. The results show that treatment of Rb 3 raised the neuronal viability, reduced the leakage of lactate dehydrogenase, and inhibited NMDA-elicited Ca 2+ influx in a dose-dependent manner. In the presence of Rb 3 , NMDA-evoked peak current was inhibited, and Ca 2+ -induced desensitization of NMDA current was facilitated. It is suggested that ginsenoside Rb 3 could exert a neuroprotective role on hippocampal neurons, a role which was partly mediated by the facilitation of Ca 2+ -dependent deactivation of NMDA receptors, and the resultant reduction of intracellular free Ca 2+ level.
Introduction
Treatment of ischemic cerebral stroke remains unsatisfactory because of the complexity of the pathophysiological processes of brain injury (Labiche and Grotta, 2004; Sugawara et al., 2004; Lo et al., 2005; Segura et al., 2008) and the difficulties of neuronal regeneration (Popa-Wagner et al., 2007; Hess and Borlongan, 2008) . Almost no neuroprotective agents with affirmative curative efficacy could be used clinically to alleviate neuronal damage (Cheng et al., 2004; Green, 2008; Segura et al., 2008) . However, the recent success of a
Cell Culture
Briefly, the hippocampi isolated from one-day-old newborn rats were cut into pieces, and digested with 0.125% trypsin at 37 • C for 15 min. The digested brain tissue pieces were mildly triturated in a culture dish using heat-polished pipettes to dissociate hippocampal cells. The dissociated cells were then plated on to a 96-well plate or a coverslip (1 × 1 cm) coated with poly-L-lysine overnight. Cells were grown in the plating medium with 85% high glucose Dulbecco's Minimum Essential Medium (DMEM, 12100-046), 15% fetal bovine serum (Hyclone, Logan, USA), and 10 6 U/L penicillin-streptomycin (Merro Pharmaceutical Factory, Dalian, China) . Six hours later, the plating medium was changed to the feeding medium with 98% neurobasal medium (21103-049), 2% B27 (17504-044), 2 mM glutamine, and 10 6 U/L penicillin-streptomycin. The day of plating was counted as day-in-vitro (DIV) 0. On DIV 3, cytosine arabinoside (10 µM) was added to prevent proliferation of glial cells. The feeding medium was changed every 3 days. Cultures were maintained in a 5% CO 2 incubator at 37 • C. The cultured neurons on DIV 8 were used for the subsequent experiments.
Excitotoxicity Induced by NMDA Exposure
Cultured hippocampal neurons were rinsed twice with extracellular solution containing (in mM): NaCl 145, KCl 3, HEPES 10, CaCl 2 •2H 2 O 3, MgCl 2 •6H 2 O 2, and glucose 8. The neurons were then incubated at 37 • C in DMEM containing NMDA (1 mM) for different durations. After exposure of NMDA, the neurons were washed twice with extracellular solution, and subsequently fed with high glucose DMEM and returned to the normal incubator for a 24-hours recovery. The neurons for the control underwent the same procedure without the exposure of NMDA.
Measurements of Cell Damage
Cell viability was assessed by MTT method. 24 hours after glutamate treatment, the culture medium was removed from the 96-well plate, and the neurons were rinsed twice with extracellular solution. MTT solution (25 µl) was added into each well (final concentration 0.1%). Following incubation at 37 • C for 4 hours, 100 µl sodium dodecylsulphate solution of 20% (dissolved in dimethylformamide) was mixed into each well to dissolve the resultant dark blue crystal for 20 hours. Absorbance of each well was measured at a wavelength of 570 nm (OD 570) with the Universal Microplate Reader (ELx 800, BioTek Instruments, Inc., Winooski, USA).
Neuronal damage was evaluated by measurement of lactate dehydrogenase (LDH) leaked into the culture medium. LDH activity was measured followed by the protocol of the LDH kit (Jiancheng Bioengineering Institute, Nanjing, China). Twenty hours after glutamate treatment, 0.4 ml of culture medium was mixed with 1.3 ml nicotinamide adenine dinucleotide (NADH) solution and 1.3 ml sodium pyruvate solution. Both agents were dissolved in potassium phosphate buffer (100 mM K 2 HPO 4 , adjusted to pH 7.5 with KH 2 PO 4 ). The mixed solution was immediately assayed with a spectrophotometer (UV-2450, Shimadzu Corporation, Kyoto, Japan) by monitoring the conversion of NADH to NAD at 340 nm at 37 • C, coupled with the reduction of pyruvate to lactate. LDH activity is expressed as units/ml, with one unit of activity representing the amount of LDH that causes a decrease of 0.001 absorbance unit of NADH per minute in the presence of sodium pyruvate.
Intracellular Free Ca 2+ Imaging
For intracellular free Ca 2+ imaging, Fluo-3/AM was used as a fluorescent Ca 2+ indicator. Fluo-3/AM was dissolved in DMSO with a final work concentration of 0.1% DMSO. The cultured hippocampal neurons were loaded with 5 µM Fluo-3/AM for 45 min at 37 • C in extracellular solution. After being washed three times with extracellular solution, the neurons were incubated at 37 • C for another 30 min to complete the deesterification of Fluo-3/AM. Intensity of fluorescence with the excitation wavelength at 485 nm and emission wavelength at 525 nm was recorded every 30 sec for 5 min by using a laser scanning confocal microscope (TCS SP2, Leica Microsystems, Heidelberg, Germany). All image data were collected and analyzed with the Leica control software of the microscope. The increase of intracellular free Ca 2+ was determined according to the following equation: Ca 2+ influx (%) = (F 525 F base,525 )/F base,525 × 100, where F 525 is the fluorescence intensity measured after each treatment, and F base,525 the basal fluorescence intensity.
Recording of NMDA-Activated Currents
NMDA current (I NMDA ) was recorded via a pipette filled with a pipette solution containing (in mM): CH 3 O 3 SCs 135, NaCl 8, HEPES 10, EGTA 0.5, Mg-ATP 4, and Na-GTP 0.3. The pH was adjusted to 7.25 with 1 M CsOH, and the osmolarity to 285 mOsm with sucrose. Conventional whole-cell patch-clamp technique was adopted with the neurons in a bath solution containing (in mM): NaCl 150, KCl 3, HEPES 10, CaCl 2 •2H 2 O 3, glucose 8 (pH 7.4 adjusted with 1 M NaOH, and osmolarity 300-310 mOsm adjusted with sucrose). Amplifier MultiClamp 700A, AD converter Digidata 1320A and software pCLAMP 8.0 (Axon Instruments, Forster City, USA) were used. When filled with the solution, the pipette had a resistance of 5-10 M . The junction potential between the pipette and the bath solution was −9.9 mV. This value was calculated using the junction potential calculation system of Clampex 8.0, pCLAMP 8.0, and nulled just before forming giga-seal. In most experiments, series resistance (Rs) before compensation was 10-20 M . Routinely, 70-80% of the Rs were compensated. Only neurons with Rs less than 20 M were selected for further tests. Membrane potential was held at −70 mV during the recording of I NMDA .
In order to record I NMDA , NMDA was applied to each cultured neuron via a perfusion system MPS-2 (World Precision Instruments, Sarasota, USA). The tip (250 µm diameter) of a drug application pipette was usually placed 100 µm away from the cell recorded. The bath was continuously perfused with the bath solution throughout all experiments. All current responses were elicited in this solution except those indicated elsewhere and at an ambient temperature of 23-25 • C. The desensitization degree of NMDA currents was determined by the following equation: I d = 1-I ss /I p , where I p indicates the peak current, and I ss the steady state current of I NMDA (Fig. 1) . 
Drug Application
Ginsenoside Rb 3 , AP-4, MK-801 and glycine were dissolved in the culture medium, extracellular solution or bath solution as needed, and administered simultaneously with NMDA.
Data Analysis
The softwares Clampfit 8.0 (Axon Instruments, Forster City, USA) and SigmaPlot 2001 (Jandel Scientific, Costa Madre, USA) were applied for data analysis and plotting in the present study. All data are presented as mean ± SE. Student's t-test was used for statistical analysis of data between two groups. Data of multiple groups were analyzed with oneway ANOVA and post hoc Newman-Keuls' test. Differences were considered statistically significant at a level of p < 0.05.
Results

Rb 3 Inhibition of NMDA-Induced Excitotoxicity
When the cultured hippocampal neurons were exposed to 1 mM NMDA with increasing duration (from 15 min to 120 min), LDH leakage was enhanced in a time-dependent manner ( Fig. 2A, p < 0.05) . After exposure to NMDA for 60 min, LDH leakage was increased significantly from 22.9 ± 7.7 U/ml/min of the control to 63.9 ± 1.4 U/ml/min ( Fig. 2A , p < 0.05). In the presence of ginsenoside Rb 3 , however, the leakage of LDH was reduced as a function of the concentration of ginsenoside Rb 3 . (Fig. 2B, p < 0.05 or 0.01) . Similarly, ginsenoside Rb 3 dose-dependently inhibited the reduction of cell viability induced by a 60-min exposure to 1 mM NMDA (Fig. 2C , p < 0.05 or 0.01). However, 30 µM ginsenoside Rb 3 did not further inhibit the leakage of LDH or elevate the cell viability of hippocampal neurons after NMDA exposure (Figs. 2B and 2C) .
Inhibition of Rb 3 on NMDA-Elicited Ca 2+ Influx
After a period of control records, 1 mM NMDA was added and an abundant Ca 2+ influx in the cultured hippocampal neurons was elicited (Fig. 3B ). This elevation of intracellular free Ca 2+ concentration was dose-dependently blocked by AP-4, an NMDA receptor antagonist, and MK-801, an open channel blocker (Fig. 3E, p < 0.05 or 0.01) . With a simultaneous application of 1 nM to 3 µM ginsenoside Rb 3, the NMDA-elicited Ca 2+ influx was reduced dose-dependently (Fig. 3E, p < after the administration of 3 µM ginsenoside Rb 3 (Fig. 3E , p < 0.01). When the extracellular Ca 2+ level was elevated, the NMDA-elicited Ca 2+ influx was increased in a dose-dependent manner (Fig. 3F) , however, ginsenoside Rb 3 (0.01 µM) significantly inhibited this dosedependent increase when the extracellular Ca 2+ concentration at1 and 3 mM (Fig. 3F, 
Influence of Rb 3 on NMDA-Elicited Current and Ca 2+ -Dependent Deactivation
NMDA elicited current response from 85% of the cultured hippocampal neurons (n = 200) in a concentration-dependent manner. An addition of 10 µM glycine remarkably increased I NMDA , and shifted the dose-response curve of I NMDA to the left. Meanwhile, as compared to the control, the desensitization degree (I d ) was decreased for almost all current responses elicited by any concentration of NMDA in the presence of 10 µM glycine (data not shown). Ginsenoside Rb 3 itself did not evoke any current response in the cultured hippocampal neurons, but reduced NMDA-elicited peak current to different extents and facilitated the desensitization course at the same time (Fig. 4A) . The glycine-independent desensitization, I NMDA was measured in 1 µM glycine and 3 mM extracellular Ca 2+ . For measurement of the glycine-dependent desensitization, I NMDA was elicited with maintained 3 mM Ca 2+ , and glycine was applied increasingly from 0.01 µM to 10 µM. Ca 2+ -dependent deactivation was determined when I NMDA was recorded with the concentration of glycine maintained at 1 µM and the extracellular Ca 2+ level was increased from 0.03 mM to 3 mM. Unfortunately, ginsenoside Rb 3 at 0.01-30 µM did not exert constant influence on both the glycine-dependent and glycine-independent desensitizations of I NMDA (data not shown). However, ginsenoside Rb 3 facilitated the Ca 2+ -dependent deactivation of I NMDA , i.e., as shown in Fig. 4B , the peak response was reduced and the desensitization degree (I d ) was increased. At the extracellular Ca 2+ concentration at 1 and 3 mM, I d was significantly elevated by ginsenoside Rb 3 from 0.45 ± 0.06 and 0.50 ± 0.07 to 0.77 ± 0.13 and 0.98 ± 0.07 respectively (Fig. 4C, p < 0.01) .
Discussion
The present study proved for the first time that ginsenoside Rb 3 could protect cultured rat hippocampal neurons from NMDA-induced excitotoxicity. We found that Rb 3 in a dosedependent manner reduced LDH leakage from neurons and raised neuronal viability after NMDA exposure. Meanwhile, ginsenoside Rb 3 inhibited NMDAR-mediated Ca 2+ influx dose-dependently. It is suggested that ginsenoside Rb 3 could exert a neuroprotective effect on neurons and an inhibitory influence of Rb 3 on NMDA receptors is attributable.
The neuroprotective effect of ginsenoside Rb 3 that we observed in the present study is consistent with several studies we had reported in Chinese journals (Fan et al., 2006; Shen et al., 2006a; 2006b; Jiang et al., 2007a) . We have found protective effects of ginsenoside Rb 3 on oxygen/glucose deprived hippocampal slices (Shen et al., 2006b; Jiang et al., 2007a) , glutamate-exposed hippocampal neurons (Shen et al., 2006a) , hypoxia-treated hippocampal (Shen et al., 2006b) or cortical neurons (Li et al., 2004) , and rat brain with middle cerebral artery occlusion (Fan et al., 2006) . Rb 3 in these studies reduced the release of LDH and the expression of iNOS and caspase-3, elevated neuronal viability, and promoted the recovery of neuronal function. In other studies, our results have shown that ginsenoside Rb 3 could raise the number of GABA-positive hippocampal neurons in rat after hypoxic exposure (Shen et al., 2005) and inhibit the increase of persistent sodium current in cultured hippocampal neurons after oxygen/glucose deprivation (Jiang et al., 2007b) . This neuroprotective effect of ginsenoside Rb 3 presented here and reported in our previous studies leads us to add a new member into the ginsenosides family which possesses neuroprotective efficacy.
For further research on the mechanism of the neuroprotective effect of ginsenoside Rb 3 , we observed the influence of Rb 3 on the current responses elicited by NMDA in the cultured hippocampal neurons. The results showed that Rb 3 facilitated the Ca 2+ -dependent deactivation of NMDAR. Glutamate excitotoxicity is an important initial process in the pathophysiological response cascades leading to hypoxic/ischemic brain injury, in which activation of NMDAR and especially calcium overload are centrally involved (Berliocchiet al., 2005; White et al., 2000) . Therefore, the inhibitory influence of ginsenoside Rb 3 on NMDAR activity that we observed, which induces a reduction in the intracellular free Ca 2+ level while NMDAR is over-activated may partly underlie the neuroprotective effect of Rb 3 .
This inhibitory effect of Rb 3 on NMDAR has not been reported until now. However, Kim et al. (2002) have observed an inhibitory effect of total saponins and 10 ginsenosides on NMDAR, i.e., at a concentration of 10 µM, ginsenosides Rb 2 , Rd, Re, Rf, and Rg 2 had little or no significant effect while Rb 1 , Rc, Rg 3 , Rh 1 , and Rh 2 produced a notable inhibition on NMDA-induced [Ca 2+ ] i increase, and among these five effective ginsenosides, Rg 3 produced the highest inhibitory effect. Moreover, they found that Rg 3 reduced NMDAinduced current remarkably. However, they did not investigate the effect of ginsenoside Rb 3 . Their further study has revealed that ginsenoside Rg 3 antagonizes NMDA receptors through a glycine modulatory site in cultured rat hippocampal neurons. Lee et al. (2006) have reported that 20(S)-ginsenoside Rh 2 inhibits NMDAR via an interaction with polyamine-binding sites in cultured rat hippocampal neurons. Our recent study has indicated that ginsenoside Rg 1 protects neurons from hypoxic-ischemic injury partly by inhibiting Ca 2+ influx through NMDA receptors (Zhang et al., 2008) . The present study extends the research concerning the inhibitory effect of ginsenosides on NNDAR activity.
In conclusion, ginsenoside Rb 3 exerted a neuroprotective role on cultured rat hippocampal neurons subjected to excitotoxicity of NMDA. This effect was partly mediated through the facilitation of Ca 2+ -dependent deactivation of NMDA receptors, and the resultant reduction of intracellular free Ca 2+ level.
